Solid Bio Fast Tracked for Friedreich's Ataxia Gene Therapy

 Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation -

https://www.globenewswire.com/news-release/2025/01/21/3012692/0/en/Solid-Biosciences-Receives-FDA-Fast-Track-Designation-for-SGT-212-Dual-Route-of-Administration-Gene-Therapy-for-Friedreich-s-Ataxia.html